Ann Marie Schmidt
35Patents
13h-index
23Co-inventors
81Inventor score
Filing activity: May 16, 1996 → May 28, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6315995A | Methods for treating an ischemic disorder and improving stroke outcome | Chemistry; Metallurgy | 55 | Expired |
| US6316403A | Methods for treating an ischemic disorder and improving stroke outcome | Chemistry; Metallurgy | 54 | Expired |
| US6825164B1 | Method to increase cerebral blood flow in amyloid angiopathy | Chemistry; Metallurgy | 40 | Expired |
| US6677299B2 | Method to increase cerebral blood flow in amyloid angiopathy | Chemistry; Metallurgy | 38 | Expired |
| US7101838B2 | Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts | Human Necessities | 35 | Expired |
| US6670136B2 | Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof | Human Necessities | 34 | Expired |
| US5839443A | Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation | Physics | 33 | Expired |
| US6555651B2 | Ligand binding site of rage and uses thereof | Human Necessities | 29 | Expired |
| US7258857B2 | Rage-related methods for treating inflammation | Human Necessities | 22 | Expired |
| US6391300B1 | Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation | Physics | 21 | Expired |
| US6465422B1 | Method for inhibiting tumor invasion or spreading in a subject | Human Necessities | 16 | Expired |
| US6555340B1 | Nucleic acid encoding bovine extracellular rage binding protein (en-rage) | Human Necessities | 15 | Expired |
| US6790443B2 | Method for treating symptoms of diabetes | Human Necessities | 14 | Expired |
| US6753150B2 | Method for determining whether a compound is capable of inhibiting the interaction of a peptide with rage | Physics | 13 | Expired |
| US6563015B1 | Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof | Physics | 12 | Expired |
| US9650383B2 | Aldose reductase inhibitors and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US7081241B1 | Extracellular rage binding protein (EN-RAGE) and uses thereof | Human Necessities | 11 | Expired |
| US7026444B2 | Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof | Human Necessities | 10 | Expired |
| US7125675B2 | Method for inhibiting tumor invasion or spreading in a subject | Human Necessities | 10 | Expired |
| US10052324B2 | Aldose reductase inhibitors and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US7732400B2 | Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury | Physics | 8 | Active |
| US10265320B2 | Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US7494972B2 | Method for inhibiting accelerated atherosclerosis in a subject suffering from hypercholesterolemia or hypertriglyceridemia | Human Necessities | 4 | Expired |
| US11529349B2 | Aldose reductase inhibitors and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10639306B2 | Aldose reductase inhibitors and uses thereof | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.